Artificial Intelligence Tools and Their Ability to Refine Skin Cancer Diagnostics
Keerti Ganesan
16/10/2026
Basal cell carcinoma, squamous cell carcinoma, and melanoma – the most common forms of skin cancer – have some of the highest global incidence rates. Despite representing a small percentage of total skin cancer cases, melanoma accounts for the majority of skin cancer-related deaths. Given that early detection and accurate diagnosis are vital for improving mortality rates, researchers have begun to explore artificial intelligence and robotic technologies in dermatology for malignancy detection (Shin et al., 2025). This paper examines current approaches to melanoma diagnosis and treatment, including convolutional neural networks (CNNs), three-dimensional total body photography, explainable artificial intelligence (XAI), automated lesion mapping systems, and augmented reality surgical navigation. In addition, the paper analyzes ethical concerns around algorithmic bias, patient privacy, and the impact on physician-patient trust. AI-assisted systems can enhance diagnostic accuracy and offer suggestions to clinicians for precision-based surgical interventions. However, these technologies differ in diagnostic performance, clinical maturity, regulatory status, and practical requirements, and many remain investigational or require physician oversight. Limitations of the use of AI tools in health care include dataset diversity, interpretability, accessibility, and compliance monitoring. These discoveries suggest that AI and robotic technology have the potential to transform dermatologic oncology by being used alongside a skilled physician to improve survival rates and expand resources for skin cancer care.
